Skip to main content
Log in

One-year impact of bariatric surgery on serum anti-Mullerian-hormone levels in severely obese women

  • Reproductive Physiology and Disease
  • Published:
Journal of Assisted Reproduction and Genetics Aims and scope Submit manuscript

Abstract

Introduction

Although bariatric surgery seems to increase spontaneous fertility by improving ovulatory function in young women, its impact on ovarian reserve remains largely unknown.

Objective

To evaluate changes in serum anti-Mullerian hormone (AMH) levels in reproductive-age severely obese women after bariatric surgery (BS).

Methods

AMH levels were measured retrospectively in 39 women (mean age 34.6 ± 1.1 years, range 18–45) that underwent a sleeve gastrectomy or Roux-en-Y gastric bypass (RYGB) at baseline, and 6 and 12 months after BS. Metabolic and micronutrient status, including fasting plasma insulin and glucose, HOMA-IR, leptin, adiponectin, calcium, albumin, transthyretin, ferritin, vitamins (B9, B12, B1, A, E, D), zinc, and selenium, were assessed in all patients before and 1 year after BS.

Results

Of the patients, 79% had class-3 obesity. At 6 and 12 months, mean total weight losses (TWL) were 26 and 30%; mean excess weight losses (EWL) were 61.7 and 70.2%. Compared to baseline, AMH levels significantly decreased by 18% at 6 months, and 32% at 12 months post-operatively (p = 0.010 and p = 0.001, respectively). There was no correlation between AMH variation and changes in metabolic parameters or micronutrient levels. Remarkably, changes in AMH levels did not differ between sleeve and RYGB patients and were not correlated with EWL.

Conclusion

This pilot study shows a drastic reduction in AMH levels at 1 year after BS in reproductive-age severely obese women, which was not related to weight loss: this suggests a negative impact of BS on ovarian reserve, at least in the short term.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384:766–81.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Bernardi LA, Carnethon MR, de Chavez PJ, Ikhena DE, Neff LM, Baird DD, et al. Relationship between obesity and anti-Müllerian hormone in reproductive-aged African American women. Obes Silver Spring Md. 2017;25:229–35.

    Article  CAS  Google Scholar 

  3. Lefebvre T, Dumont A, Pigny P, Dewailly D. Effect of obesity and its related metabolic factors on serum anti-Müllerian hormone concentrations in women with and without polycystic ovaries. Reprod BioMed Online. 2017;35:325–30.

    Article  PubMed  CAS  Google Scholar 

  4. Practice Committee of the American Society for Reproductive Medicine. Obesity and reproduction: a committee opinion. Fertil Steril. 2015;104:1116–26.

    Article  Google Scholar 

  5. Escobar-Morreale HF, Santacruz E, Luque-Ramírez M, Botella Carretero JI. Prevalence of ‘obesity-associated gonadal dysfunction’ in severely obese men and women and its resolution after bariatric surgery: a systematic review and meta-analysis. Hum Reprod Update. 2017;23:390–408.

    Article  PubMed  Google Scholar 

  6. Broughton DE, Moley KH. Obesity and female infertility: potential mediators of obesity’s impact. Fertil Steril. 2017;107:840–7.

    Article  PubMed  Google Scholar 

  7. Galazis N, Docheva N, Simillis C, Nicolaides KH. Maternal and neonatal outcomes in women undergoing bariatric surgery: a systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2014;181:45–53.

    Article  PubMed  Google Scholar 

  8. Milone M, Placido GD, Musella M, Fernandez LMS, Fernandez LVS, Campana G, et al. Incidence of successful pregnancy after weight loss interventions in infertile women: a systematic review and meta-analysis of the literature. Obes Surg. 2015;26:443–51.

    Article  Google Scholar 

  9. Merhi ZO, Minkoff H, Feldman J, Macura J, Rodriguez C, Seifer DB. Relationship of bariatric surgery to Müllerian-inhibiting substance levels. Fertil Steril. 2008;90:221–4.

    Article  PubMed  CAS  Google Scholar 

  10. Bhandari S, Ganguly I, Bhandari M, Agarwal P, Singh A, Gupta N, et al. Effect of sleeve gastrectomy bariatric surgery-induced weight loss on serum AMH levels in reproductive aged women. Gynecol Endocrinol Off J Int Soc Gynecol Endocrinol 2016;32:799-802.

  11. Rochester D, Jain A, Polotsky AJ, Polotsky H, Gibbs K, Isaac B, et al. Partial recovery of luteal function after bariatric surgery in obese women. Fertil Steril. 2009;92:1410–5.

    Article  PubMed  Google Scholar 

  12. Dewailly D, Andersen CY, Balen A, Broekmans F, Dilaver N, Fanchin R, et al. The physiology and clinical utility of anti-Mullerian hormone in women. Hum Reprod Update. 2014;20:370–85.

    Article  PubMed  Google Scholar 

  13. Steiner AZ, Pritchard D, Stanczyk FZ, Kesner JS, Meadows JW, Herring AH, et al. Association between biomarkers of ovarian reserve and infertility among older women of reproductive age. JAMA. 2017;318:1367–76.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  14. Kissell KA, Danaher MR, Schisterman EF, Wactawski-Wende J, Ahrens KA, Schliep K, et al. Biological variability in serum anti-Müllerian hormone throughout the menstrual cycle in ovulatory and sporadic anovulatory cycles in eumenorrheic women. Hum Reprod. 2014;29:1764–72.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  15. Fried M, Yumuk V, Oppert JM, Scopinaro N, Torres A, Weiner R, et al. Interdisciplinary European guidelines on metabolic and bariatric surgery. Obes Surg. 2014;24:42–55.

    Article  PubMed  CAS  Google Scholar 

  16. WHO | Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia [Internet]. WHO. [cited 2017 Jul 25]. Available from: http://www.who.int/diabetes/publications/diagnosis_diabetes2006/en/

  17. de 1’Afssaps R. Prise en charge thérapeutique du patient dyslipidémique. 2005. 2017 [cited 2017 Jul 25]; Available from: http://www.jle.com/fr/revues/met/e-docs/prise_en_charge_therapeutique_du_patient_dyslipidemique._mars_2005__266098/article.phtml

  18. Buse JB, Caprio S, Cefalu WT, Ceriello A, Del Prato S, Inzucchi SE, et al. How do we define cure of diabetes? Diabetes Care. 2009;32:2133–5.

    Article  PubMed  PubMed Central  Google Scholar 

  19. João Cabrera E, Valezi AC, Delfino VDA, Lavado EL, Barbosa DS. Reduction in plasma levels of inflammatory and oxidative stress indicators after Roux-en-Y gastric bypass. Obes Surg. 2010;20:42–9.

    Article  PubMed  Google Scholar 

  20. Camastra S, Gastaldelli A, Mari A, Bonuccelli S, Scartabelli G, Frascerra S, et al. Early and longer term effects of gastric bypass surgery on tissue-specific insulin sensitivity and beta cell function in morbidly obese patients with and without type 2 diabetes. Diabetologia. 2011;54:2093–102.

    Article  PubMed  CAS  Google Scholar 

  21. Mingrone G, Cummings DE. Changes of insulin sensitivity and secretion after bariatric/metabolic surgery. Surg Obes Relat Dis Off J Am Soc Bariatr Surg. 2016;12:1199–205.

    Article  Google Scholar 

  22. Legro RS. Effects of obesity treatment on female reproduction: results do not match expectations. Fertil Steril. 2017;107:860–7.

    Article  PubMed  Google Scholar 

  23. Musella M, Milone M, Bellini M, Sosa Fernandez LM, Leongito M, Milone F. Effect of bariatric surgery on obesity-related infertility. Surg Obes Relat Dis Off J Am Soc Bariatr Surg. 2012;8:445–9.

    Article  Google Scholar 

  24. Reinehr T, Kulle A, Rothermel J, Knop C, Lass N, Bosse C, et al. Weight loss in obese girls with polycystic ovarian syndrome is associated with a decrease in anti-Muellerian hormone concentrations. Clin Endocrinol. 2017;87:185–93.

    Article  CAS  Google Scholar 

  25. Milone M, Sosa Fernandez LM, Sosa Fernandez LV, Manigrasso M, Elmore U, De Palma GD, et al. Does bariatric surgery improve assisted reproductive technology outcomes in obese infertile women? Obes Surg. 2017;27:2106–12.

    Article  PubMed  Google Scholar 

  26. Chiofalo F, Ciuoli C, Formichi C, Selmi F, Forleo R, Neri O, et al. Bariatric surgery reduces serum anti-mullerian hormone levels in obese women with and without polycystic ovarian syndrome. Obes Surg. 2017;27:1750–4.

    Article  PubMed  Google Scholar 

  27. Cetin I, Berti C, Calabrese S. Role of micronutrients in the periconceptional period. Hum Reprod Update. 2010;16:80–95.

    Article  PubMed  CAS  Google Scholar 

  28. Moslehi N, Mirmiran P, Tehrani FR, Azizi F. Current evidence on associations of nutritional factors with ovarian reserve and timing of menopause: a systematic review. Adv Nutr. 2017;8(4):597–612.

    PubMed  PubMed Central  Google Scholar 

  29. Irani M, Merhi Z. Role of vitamin D in ovarian physiology and its implication in reproduction: a systematic review. Fertil Steril. 2014;102:460–468.e3.

    Article  PubMed  CAS  Google Scholar 

  30. Chang EM, Kim YS, Won HJ, Yoon TK, Lee WS. Association between sex steroids, ovarian reserve, and vitamin D levels in healthy nonobese women. J Clin Endocrinol Metab. 2014;99:2526–32.

    Article  PubMed  CAS  Google Scholar 

  31. Pearce K, Gleeson K, Tremellen K. Serum anti-Mullerian hormone production is not correlated with seasonal fluctuations of vitamin D status in ovulatory or PCOS women. Hum Reprod. 2015;30:2171–7.

    Article  PubMed  CAS  Google Scholar 

  32. Comninos AN, Jayasena CN, Dhillo WS. The relationship between gut and adipose hormones, and reproduction. Hum Reprod Update. 2014;20:153–74.

    Article  PubMed  CAS  Google Scholar 

  33. Mitchell M, Armstrong DT, Robker RL, Norman RJ. Adipokines: implications for female fertility and obesity. Reproduction. 2005;130:583–97.

    Article  PubMed  CAS  Google Scholar 

  34. Merhi Z, Buyuk E, Berger DS, Zapantis A, Israel DD, Chua S, et al. Leptin suppresses anti-Mullerian hormone gene expression through the JAK2/STAT3 pathway in luteinized granulosa cells of women undergoing IVF. Hum Reprod Oxf Engl. 2013;28:1661–9.

    Article  CAS  Google Scholar 

  35. Olszanecka-Glinianowicz M, Madej P, Owczarek A, Chudek J, Skałba P. Circulating anti-Müllerian hormone levels in relation to nutritional status and selected adipokines levels in polycystic ovary syndrome. Clin Endocrinol. 2015;83:98–104.

    Article  CAS  Google Scholar 

  36. Dirinck E, Dirtu AC, Jorens PG, Malarvannan G, Covaci A, Gaal V, et al. Pivotal role for the visceral fat compartment in the release of persistent organic pollutants during weight loss. J Clin Endocrinol Metab. 2015;100:4463–71.

    Article  PubMed  CAS  Google Scholar 

  37. Kim M-J, Marchand P, Henegar C, Antignac J-P, Alili R, Poitou C, et al. Fate and complex pathogenic effects of dioxins and polychlorinated biphenyls in obese subjects before and after drastic weight loss. Environ Health Perspect. 2011;119:377–83.

    Article  PubMed  CAS  Google Scholar 

  38. Dirinck EL, Dirtu AC, Govindan M, Covaci A, Jorens PG, Gaal LFV. Endocrine-disrupting polychlorinated biphenyls in metabolically healthy and unhealthy obese subjects before and after weight loss: difference at the start but not at the finish. Am J Clin Nutr. 2016;103(4):989–98.

    Article  PubMed  CAS  Google Scholar 

  39. Craig JR, Jenkins TG, Carrell DT, Hotaling JM. Obesity, male infertility, and the sperm epigenome. Fertil Steril. 2017;107:848–59.

    Article  PubMed  Google Scholar 

  40. Donkin I, Versteyhe S, Ingerslev LR, Qian K, Mechta M, Nordkap L, et al. Obesity and bariatric surgery drive epigenetic variation of spermatozoa in humans. Cell Metab. 2016;23:369–78.

    Article  PubMed  CAS  Google Scholar 

  41. Sermondade N, Massin N, Boitrelle F, Pfeffer J, Eustache F, Sifer C, et al. Sperm parameters and male fertility after bariatric surgery: three case series. Reprod BioMed Online. 2012;24:206–10.

    Article  PubMed  Google Scholar 

  42. Reis LO, Dias FGF. Male fertility, obesity, and bariatric surgery. Reprod Sci Thousand Oaks Calif. 2012;19:778–85.

    Article  Google Scholar 

  43. Iliodromiti S, Anderson RA, Nelson SM. Technical and performance characteristics of anti-Müllerian hormone and antral follicle count as biomarkers of ovarian response. Hum Reprod Update. 2015;21:698–710.

    Article  PubMed  CAS  Google Scholar 

  44. Kelsey TW, Wright P, Nelson SM, Anderson RA, Wallace WHB. A validated model of serum anti-müllerian hormone from conception to menopause. PLoS One. 2011;6:e22024.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  45. Seifer DB, Baker VL, Leader B. Age-specific serum anti-Müllerian hormone values for 17,120 women presenting to fertility centers within the United States. Fertil Steril. 2011;95:747–50.

    Article  PubMed  CAS  Google Scholar 

  46. Broekmans FJ, Soules MR, Ovarian Aging FBC. Mechanisms and clinical consequences. Endocr Rev. 2008;30:465–93.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Clara Vincentelli.

Ethics declarations

Formal consent is not required for this type of retrospective study.

Conflict of interest

The authors declare that they have no conflict of interest.

Electronic supplementary material

Supplementary figure 1

Age distribution in the study population (JPG 83 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Vincentelli, C., Maraninchi, M., Valéro, R. et al. One-year impact of bariatric surgery on serum anti-Mullerian-hormone levels in severely obese women. J Assist Reprod Genet 35, 1317–1324 (2018). https://doi.org/10.1007/s10815-018-1196-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10815-018-1196-3

Keywords

Navigation